MCTD involves milder disease activity than systemic sclerosis and systemic lupus erythematosus. However mortality rate have been reported to be high in MCTD and it is known that organ damage increase over time even though disease activity decreases. Organ damage over time in patients with MCTD should be assessed further in<unk>  studies.
Mixed connective tissue disease Future or Investigational Therapies
Cystic fibrosis future or investigational therapies
Allergy primary prevention
Mixed connective tissue disease secondary prevention
Allergy secondary prevention
Multiple sclerosis cost-effectiveness of therapy
Eczema future or investigational therapies
Undifferentiated connective tissue disease medical therapy